| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | S | 5,369 | $50.61 | $271,725.09 | View Details Filing |
| Feb 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | A | 4,475 | $0.00 | $0.00 | View Details Filing |
| Feb 24, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | D | 4,475 | $0.00 | $0.00 | View Details Filing |
| Feb 18, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | A | 4,977 | $0.00 | $0.00 | View Details Filing |
| Feb 18, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | A | 2,989 | $0.00 | $0.00 | View Details Filing |
| Jan 9, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | M | 15,000 | $0.00 | $0.00 | View Details Filing |
| Jan 9, 2026 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | M | 15,000 | $12.98 | $194,700.00 | View Details Filing |